User:Larsonem7825/Epidemiology of HIV/AIDS

From Wikipedia, the free encyclopedia

Article Draft[edit]

Sections Divided:

Larson- Intro; 3 (by region); 3.1 (Sub-Saharan Africa); 3.5.1 (Caribbean); 3.7 (Western Europe); 7 (Further reading)

Ana - 3.5.2; 3.5; 3.8; 5;

Jake- 1 (Global HIV data); 3.4 (East Asia); 3.5.4 (Canada); 3.6 (Eastern Europe and Central Asia)

Zahn - 3.2; 3.3; 3.5.3; 4; 4 ref (x), 172 words (x)

AS A GROUP: Nothing in article on infections vs time; "Pandemic"

Edits as individuals: 150-375 words and 1-2 references

Edits as a group: 600-900 words and 4-5 references

Central and South America[edit]

Main article: HIV/AIDS in Latin America

The populations of Central and South America have approximately 2.1 million people currently infected with HIV [1] and this number has remained relatively unvarying with having a prevalence of approximately .4%. (citation needed) In Latin America, those infected with the disease have received help in the form of Antiretroviral treatment, with 87% of people with HIV receiving the treatment.[2]

In these regions of the American continent, only Guatemala and Honduras have national HIV prevalence of over 1%. In these countries, HIV-infected men outnumber HIV-infected women by roughly 3:1.[3]

With HIV/AIDS incidence levels rising in Central America, education is the most important step in controlling the spread of this disease. In Central America, many people do not have access to treatment drugs. This results in 8–14% of people dying from AIDS in Honduras. To reduce the incidence levels of HIV/AIDS, education and drug access needs to improve.[4] Nonetheless, there has been a 21% decline since 2010 in AIDS-related deaths.[5]

In 2020, 92% out of around 100,00 new HIV infections were constituted by key populations and their sexual partners, demonstrating the inability of HIV programs to fill the remaining gaps in the most vulnerable populations.[6]

In a study of immigrants traveling to Europe, all asymptomatic persons were tested for a variety of infectious diseases. The prevalence of HIV among the 383 immigrants from Latin America was low, with only one person testing positive for a HIV infection. This data was collected from a group of immigrants with the majority from Bolivia, Ecuador and Colombia.[7]

Oceania[edit]

Main articles: HIV/AIDS in Australia, HIV/AIDS in New Zealand, and HIV/AIDS in Papua New Guinea

There is a very large range of national situations regarding AIDS and HIV in this region. This is due in part to the large distances between the islands of Oceania. The wide range of development in the region also plays an important role. The prevalence is estimated at between 0.2% and 0.7%, with between 45,000 and 120,000 adults and children currently infected with HIV.[3]

Papua New Guinea has one of the most serious AIDS epidemics in the region. According to UNAIDS, HIV cases in the country have been increasing at a rate of 30 percent annually since 1997, and the country's HIV prevalence rate in late 2006 was 1.3%.[8]

See also[edit]

Lead[edit]

According to the World Health Organization (WHO), the prevalence of HIV in the Africa Region was estimated at 1.1 million people as of 2018. [9] The African Region accounts for two thirds of the incidence of HIV around the world. [9]

World Graph is from 2009, could be updated. Found a good map with HIV prevalence as of 2021 done by UNAIDS. Was not able to add this picture because licensing. I will add a note in the talk page but for now I will not be adding this to our project.

as of 2021, HIV/AIDS has killed approximately 40.1 million people, and approximately 38.4 million people are infected with HIV globally.[10] Of these 38.4 million people, 75% are receiving antiretroviral treatment. [11]

Global HIV data[edit]

HIV/AIDS related deaths, HIV Incidence Rate, and HIV Prevalence Rate on a Global Scale
Year Deaths due to HIV/AIDS globally[12] HIV Infection Incidence Rate globally[13] HIV Infection Prevalence Rate Globally[13]
1990 336 387 2 100 000 8 500 000
1995 939 400 3 200 000 18 600 000
2000 1 560 000 2 900 000 26 000 000
2005 1 830 000 2 500 000 28 500 000
2010 1 370 000 2 200 000 30 800 000
2015 1 030 000 1 900 000 34 400 000
2021[14] 650 000 1 500 000 38 400 000
Prevalence, new cases and deaths from HIV/AIDS, World, 1990-2019

It is crucial to have HIV tests available for individuals worldwide since it can help individuals detect the status of their disease from an early onset, seek help, and prevent further spread through the practice of suggestive safety precautions. Testing can be done for those between the ages of 13 and 64. The CDC recommends testing for HIV at least once for routine health care. HIV tests are have high accuracy and the tests come in in the form of antibody tests, antigen/antibody tests, and NATS (nucleic acid test). [15]

Worldwide there is a common stigma and discrimination surrounding HIV/AIDS. Respectively, infected patients are more subject to judgement, harassment, and acts of violence and come from marginalized areas where it is common to engage in illegal practices in exchange for money, drugs, or other exchangeable forms of currency.[16]

By Region[edit]

Annual AIDS deaths have been continually declining since 2005 as antiretroviral therapy (ART) has become more widely available.[17] (Citation added)

We need to edit the data in the table labeled "2020 HIV Regional data" [14]. The citation that they provided is a fact sheet from 2021 and yet they have everything labeled as 2020. They also don't have all the correct statistical numbers plugged in. Refer to regional data fact sheet provided in their citation. They must have gotten their information from UNAIDS Data 2021 (pg. 44). [18]

Regional Data 2021[13]
Region Estimated Number of Adults and

Children Living with HIV infection

Adult prevalence (%)

Ages 15-49

Adult HIV Incidence Rate

(per 1000 people)

Estimated adult and

child deaths during 2021

People on Antiretroviral

Treatment (ART)

Percent of People

on ART

Eastern and Southern Africa 20 600 000 6.2 2.39 280 000 16 200 000 78
Asia and Pacific 6 000 000 0.2 0.10 140 000 4 000 000 66
West and Central Africa 5 000 000 1.3 0.46 140 000 3 900 000 78
Latin America 2 200 000 0.5 0.30 29 000 1 500 000 69
Caribbean 330 000 1.2 0.57 5700 230 000 70
Middle east and North Africa 180 000 <0.1 0.06 5100 88 000 50
Eastern Europe

and Central Asia

1 800 000 1.1 1.00 44 000 930 000 51
Western and Central Europe

and North America

2 300 000 0.3 0.12 13 000 1 900 000 85
Global 38 400 000 0.7 0.31 650 000 28 700 000 75

Sub-Saharan Africa[edit]

Sub-Saharan Africa remains the hardest-hit region. HIV infection is becoming endemic in sub-Saharan Africa, which is home to just over 12% of the world's population but two-thirds of all people infected with HIV.[19] As of 2022, it is estimated that the adult HIV prevalence rate is 6.2%, a 1.2% increase from data reported in the 2011 UNAIDS World Aids Day Report.[19] [20] (think about moving this information to the intro material or regional material and just having statistics for Sub-Sahara here)

The UNAIDS 2021 data estimates that about 58% of the HIV 4000 incidences per day are in Sub-Saharan Africa. [21]

Eastern Africa also experiences relatively high levels of prevalence with estimates above 10% in some countries, although there are signs that the pandemic is declining in this region. West Africa on the other hand has been much less affected by the pandemic. Several countries reportedly have prevalence rates around 2 to 3%, and no country has rates above 10%. In Nigeria and Côte d'Ivoire, two of the region's most populous countries, between 5 and 7% of adults are reported to carry the virus.[citation needed] (Can't find resource for these numbers. Will probably replace with...) According to the statistical release form the Republic of South Africa in 2020, the prevalence rate of HIV infections among adults ages 15-49 was 18.7% but the overall population in South Africa has a prevalence rate of 13%.[22] As of 2021, UNAIDS data from the eastern and southern countries in Africa showed the HIV prevalence rate to be 6.2% in adults ages 15-49.[13]

Although Eastern and Southern Africa have a heavier burden of disease they have also shown much resilience in their response to HIV. [23]

It is important to work towards eliminating Mother-to-child transmission of HIV. Due to a lack of testing, a shortage in antenatal therapies and through the feeding of contaminated breast milk, 590,000 infants born in developing countries are infected with HIV-1 per year. [24] In 2000, the World Health Organization estimated that 25% of the units of blood transfused in Africa were not tested for HIV, and that 10% of HIV infections in Africa were transmitted via blood.[25]

According to a graph done by UNAIDS, there were 4 200 000 people living with HIV in South Africa in 2005. This was an increase of 400 000 people since 2003.[26] As of 2018, the prevalence of HIV in Eastern and Southern Africa combined was 1.8 million. This number only represents children and adolescents (Ages 0-19). As for those ages 15-24 in this region of Africa, the incidence rate (2018) was 290 000. About 203 000 of those infected were females.[26] Females in Sub-Saharan Africa continue to be adversely affected by HIV with data that reveals women 15-24 years of age are two times as likely to contract HIV compared to their male counterparts. [27] However, it has been noted, that empowering women when it comes to education has an effect on lowering their risk of becoming infected with HIV. [27] Data from Sub-Saharan Africa also shows that women are more likely to get tested for HIV, therefor a higher percentage of women compared to men are aware that they have HIV.[27] There are also a higher percentage of women who are receiving treatment and women are more likely to continue with treatment once started.[27]

Although HIV infection rates are much lower in Nigeria than in other African countries, the size of Nigeria's population meant that by the end of 2003, there were an estimated 3.6 million people infected. On the other hand, Uganda, Zambia, Senegal, and most recently Botswana have begun intervention and educational measures to slow the spread of HIV. Uganda has succeeded in actually reducing its HIV infection rate.[28]

During COVID-19, some countries in South and East Africa were able to set up treatment sites that provided 1.8 million individuals with a larger supply of antiretroviral (ART) medication that could sustain them for longer than the typical 3 months. [27] In the quarterly report following lockdown, they saw a 10% decrease in the number of individuals that experienced treatment interruptions from the quarter before lockdown. [27] South Africa also saw that those infected with HIV had a great risk of complications if they contracted the COVID-19 virus, and more so if they were not receiving ART. [27] The other issue seen before the COVID-19 pandemic arrived was the lack of health care workers. In a bar graph created by the World Health Organization (WHO) comparing regions and globally, Sub-Saharan Africa had the least number of health professionals per 10 000 people. [29]

Middle East and North Africa[edit]

HIV/AIDS prevalence among the adult population (15-49) in the Middle East and North Africa (MENA) is estimated less than 0.1 between 1990 and 2018. This is the lowest prevalence rate compared to other regions in the world.[30] Although the prevalence is low, concerns remain in this region. First, unlike the global downward trend in new HIV infections and AIDS-related deaths, the numbers have continuously increased in the MENA.[31] Second, compared to the global rate of antiretroviral therapy (62%),[32] the MENA region's rate is far below in 2020 (43%).[33] The low participation of ART increases not only the number of AIDS-related deaths but the risk of mother-to-baby HIV infections, in which the MENA (24.7%) shows relatively high rates compared to other regions, for example, southern Africa (10%), Asia and the Pacific (17%).[30] It is estimated that only one in five individuals in need of antiretroviral therapy (ART) will receive it, and even less than 10% in women and children.[34] Key population at high risk in this region is identified as injection drug users, female sex workers and men who have sex with men.[30]

In the MENA, roughly 230,000 people are living with HIV as of 2020, a slight decrease from 240,000 in 2018[35][33] and Iran accounted for approximately one-quarter (61,000) of the population with HIV followed by Sudan (59,000).[35] Sudan (5,200), Iran (4,400) and Egypt (3,600) took up more than 60% of the number of new infections themselves in the MENA (20,000). Roughly two-thirds of AIDS-related deaths in this region happened in these countries for the year 2018.[35]

Key population at high risk in this region is identified as injection drug users, female sex workers and men who have sex with men.[30]

South and South-East Asia[edit]

Main article: HIV/AIDS in Asia

The geographical size and human diversity of South and South-East Asia have resulted in HIV epidemics differing across the region.[citation needed]

In South and Southeast Asia, the HIV epidemic remains largely concentrated in injecting drug users (or people who inject drugs, PWID), men who have sex with men (MSM), transgender individuals, sex workers, and clients of sex workers and their immediate sexual partners.[36][37] In the Philippines, in particular, sexual contact between males comprise the majority of new infections. An HIV surveillance study conducted by Dr. Louie Mar Gangcuangco and colleagues from the University of the Philippines-Philippine General Hospital showed that out of 406 MSM tested for HIV in Metro Manila, HIV prevalence was 11.8% (95% confidence interval: 8.7- 15.0).[38][39]

Migrants, in particular, are vulnerable and 67% of those infected in Bangladesh and 41% in Nepal are migrants returning from India.[36] This is in part due to human trafficking and exploitation, but also because even those migrants who willingly go to India in search of work are often afraid to access state health services due to concerns over their immigration status.[36]

Overall, integration of treatment and prevention programs has greatly increased in recent times since 2010. Condom programs have been most prevalent in the region and testing has increased disease HIV status awareness from 26 to 89% in the general region.[37] Antiretroviral therapy has been successful in Thailand in eliminating mother-to-child transmission of both HIV and syphillis.[37] Some countries have implemented needle and syringe exchange programs to combat PWID-related infections. In 2015, Bangladesh, India, Myanmar, Indonesia, Nepal, and Thailand all achieved the 200 needles distributed per PWID standard set by the World Health Organization (WHO) five years before the 2020 goal.[40] Throughout the region, countries have seen a decrease in AIDS-related deaths and new HIV infections from 2010 to 2015, with the exception of Indonesia[37]. (why?)

East Asia [edit][edit]

Main article: HIV/AIDS in Asia

The national HIV prevalence levels in East Asia is 0.1% in the adult (15–49) group. However, due to the large populations of many East Asian nations, this low national HIV prevalence still means that large numbers of people are infected with HIV. The picture in this region is dominated by China. Much of the current spread of HIV in China is through injecting drug use and paid sex. In China, UNAIDS estimated the number to be between 390,000 and 1.1 million, following a previous report that ranged from 430,000 to 1.5 million people.[citation needed] <-(Citation to Chinadaily added) East Asia has an estimates 3.5 million people living with HIV, with prevalence low in the 15-49 age range. HIV/AIDS has remained somewhat stable with an approximated 3.5 million cases since 2005. Thailand is the only east Asian country with a over 1% HIV prevalence, which has declined from 1.7% in 2001 to 1.1% in 2015. No cases have been reported in the Democratic People's Republic of Korea. [41]

In the rural areas of China, where large numbers of farmers, especially in Henan province, participated in unclean blood transfusions; estimates of those infected are in the tens of thousands. In Japan, [percent affecting homosexual men], with the remainder occurring in heterosexual contact, injection drug use, and unknown means.[citation needed] <-(Citation added from NCBI) In East Asia, men who have sex with men account for 18% of new HIV/AIDS cases and are therefore a key affected group along with sex workers and their clients who makeup 29% of new cases. This is also a noteworthy aspect because men who have sex with men had a prevalence of at least 5% or higher in countries in Asia and Pacific.

Americas[edit]

Caribbean[edit]

There has been a significant decrease in the number of infections per year in the Caribbean.[20] There is a visible decrease in a graph presented by UNAIDS showing the number of new HIV infections from years 2015-2020. [20] There has also been a 50% decrease in the number of deaths due to AIDS since 2010.[20]

The region's adult prevalence rate in 2011 was 0.9%.[42] As of 2021, the prevalence rate among adults ages 15-49 was 1.2% with 14 000 new HIV cases presenting in both adults and children which is a 28% decrease from 2010.[13][20]

with national rates ranging up to 2.7%.[43] (This source did not add up, so will be deleting this piece of information since it doesn't really make sense).

with two-thirds of AIDS cases in this region attributed to this route. Sex between men is also a significant route of transmission, even though it is heavily stigmatized and illegal in many areas. HIV transmission through injecting drug use remains rare, except in Bermuda and Puerto Rico.[44]

According to the UNAIDS Global AIDS Update 2022, there is a significant gap when it comes to children and adults alike receiving treatments which is playing a part in inhibiting the world from reaching its 2023 goal of 75% viral suppression among children.[20] This could be in part due to the high cost for treatment and services rounding to an estimated US$ 725 per person per year.[20]

United States[edit]

Main article: HIV/AIDS in the United States

Since the epidemic began in the early 1980s, 1,216,917 people have been diagnosed with AIDS in the US. 1.2 million people of the 2019 United States population were living with HIV, with 1 in 8 people unaware of their infection status. 34,800 of which were new cases, which is an 8% decrease in comparison to 2015 statistics[45] In 2016, 14% of the 1.1 million people over age 13 living with HIV were unaware of their infection.[46] The most recent CDC HIV Surveillance Report estimates that 38,281 new cases of HIV were diagnosed in the United States in 2017, a rate of 11.8 per 100,000 population.[47] Men who have sex with men accounted for approximately 8 out of 10 HIV diagnoses among males. Regionally, the population rates (per 100,000 people) of persons diagnosed with HIV infection in 2015 were highest in the South (16.8), followed by the Northeast (11.6), the West (9.8), and the Midwest (7.6).[48] Since 2015, HIV infections have decreased 8%, with 30,635 new cases reported in 2020. The highest incidence rates have continued to be measured in the South, with approximately 13% of the population unaware of their HIV status. [49]

The most frequent mode of transmission of HIV continues to be through male homosexual sexual relations. In general, recent studies have shown that 1 in 6 gay and bisexual men were infected with HIV.[50] As of 2014, in the United States, 83% of new HIV diagnoses among all males aged 13 and older and 67% of the total estimated new diagnoses were among homosexual and bisexual men. Those aged 13 to 24 also accounted for an estimated 92% of new HIV diagnoses among all men in their age group.[51]

A review of studies containing data regarding the prevalence of HIV in transgender women found that nearly 11.8% self-reported that they were infected with HIV.[52] Along with these findings, recent studies have also shown that transgender women are 34 times more likely to have HIV than other women.[50] A 2008 review of HIV studies among transgender women found that 28 percent tested positive for HIV.[53] In the National Transgender Discrimination Survey, 20.23% of black respondents reported being HIV-positive, with an additional 10% reporting that they were unaware of their status.[54]

AIDS is one of the top three causes of death for African American men aged 25–54 and for African American women aged 35–44 years in the United States of America. In the United States, African Americans make up about 48% of the total HIV-positive population and make up more than half of new HIV cases, despite making up only 12% of the population. The main route of transmission for women is through unprotected heterosexual sex. African American women are 19 times more likely to contract HIV than other women.[55]

By 2008, there was increased awareness that young African-American women in particular were at high risk for HIV infection.[56] In 2010, African Americans made up 10% of the population but about half of the HIV/AIDS cases nationwide.[57] This disparity is attributed in part to a lack of information about AIDS and a perception that they are not vulnerable, as well as to limited access to health-care resources and a higher likelihood of sexual contact with at-risk male sexual partners.[58]

Since 1985, the incidence of HIV infection among women had been steadily increasing. In 2005 it was estimated that at least 27% of new HIV infections were in women.[59] There has been increasing concern for the concurrency of violence surrounding women infected with HIV. In 2012, a meta-analysis showed that the rates of psychological trauma, including Intimate Partner Violence and PTSD in HIV positive women were more than five times and twice the national averages, respectively.[60] In 2013, the White House commissioned an Interagency Federal Working Group to address the intersection of violence and women infected with HIV.[61]

There are also geographic disparities in AIDS prevalence in the United States, where it is most common in the large cities of California, esp. Los Angeles and San Francisco and the East Coast, ex. New York City and in urban cities of the Deep South.[62] Rates are lower in Utah, Texas, and Northern Florida.[62] Washington, D.C., the nation's capital, has the nation's highest rate of infection, at 3%. This rate is comparable to what is seen in west Africa, and is considered a severe epidemic.[63]

In the United States in particular, a new wave of infection is being blamed on the use of methamphetamine, known as crystal meth. Research presented at the 12th Annual Retrovirus Conference in Boston in February 2005 concluded that using crystal meth or cocaine is the biggest single risk factor for becoming HIV+ among US gay men, contributing 29% of the overall risk of becoming positive and 28% of the overall risk of being the receptive partner in anal sex.[64]

In addition, several renowned clinical psychologists now cite methamphetamine as the biggest problem facing gay men today, including Michael Majeski, who believes meth is the catalyst for at least 80% of seroconversions currently occurring across the United States, and Tony Zimbardi, who calls methamphetamine the number one cause of HIV transmission, and says that high rates of new HIV infection are not being found among non-crystal users. In addition, various HIV and STD clinics across the United States report anecdotal evidence that 75% of new HIV seroconversions they deal with are methamphetamine-related; indeed, in Los Angeles, methamphetamine usage is regarded as the main cause of HIV seroconversion among gay men in their late thirties.[64] The chemical "methamphetamine", in and of itself, cannot infect someone with HIV.

Canada [edit][edit]

Main article: HIV/AIDS in Canada

In 2016, there were approximately 63,100 people living with HIV/AIDS in Canada. It was estimated that 9090 persons were living with undiagnosed HIV at the end of 2016. Mortality has decreased due to medical advances against HIV/AIDS, especially highly active antiretroviral therapy (HAART). HIV/AIDS prevalence is increasing most rapidly amongst aboriginal Canadians, with 11.3% of new infections in 2016. Canada aims to reach goals of the 90-90-90 strategy set by Join United Nations Programme on HIV/AIDS (UNAIDS) where 90% of those positive and living with HIV know their status, 90% of the diagnosed able to receive antiretroviral treatment, and 90% on treatment able to achieve viral suppression to eliminate the epidemic of AIDS by 2030.[65]

Eastern Europe and Central Asia [edit][edit]

Main article: HIV/AIDS in Eastern Europe and Central Asia

There is growing concern about a rapidly growing epidemic in Eastern Europe and Central Asia, where an estimated 1.23–3.7 million people were infected as of December 2011, though the adult (15–49) prevalence rate is low (1.1%). The rate of HIV infections began to grow rapidly from the mid-1990s, due to social and economic collapse, increased levels of intravenous drug use and increased numbers of sex workers. By 2010 the number of reported cases in Russia was over 450,000 according to the World Health Organization, up from 15,000 in 1995 and 190,000 in 2002. In June 2021, there are over 1.1 million people in Russia living with HIV.[citation needed] <-(added citation from georgetown.edu)

Ukraine and Estonia also have growing numbers of infected people, with estimates of 240,000 and 7,400 respectively in 2018. Also, transmission of HIV is increasing through sexual contact and drug use among the young (<30 years). In this region there were between 130,000 to 180,000 new HIV infections reported in 2021.[66] <-(Linked to Unaids.org)

Western Europe[edit]

In most countries of Western Europe, AIDS cases have fallen to levels not seen since the original outbreak; many attribute this trend to aggressive educational campaigns, screening of blood transfusions and increased use of condoms. Also, the death rate from AIDS in Western Europe has fallen sharply, as new AIDS therapies have proven to be an effective (though expensive) means of suppressing HIV.[67]

In this area, the routes of transmission of HIV is diverse, including paid sex, injecting drug use, mother to child, male with male sex and heterosexual sex.[67] However, many new infections in this region occur through contact with HIV-infected individuals from other regions. The adult (15–49) prevalence in this region is 0.3% with between 570,000 and 890,000 people currently infected with HIV. Due to the availability of antiretroviral therapy, AIDS deaths have stayed low since the lows of the late 1990s. However, in some countries, a large share of HIV infections remain undiagnosed and there is worrying evidence of antiretroviral drug resistance among some newly HIV-infected individuals in this region.[67]

AIDS research and society[edit]

In June 2001, the United Nations held a Special General Assembly to intensify international action to fight the HIV/AIDS pandemic as a global health issue, and to mobilize the resources needed towards this aim, labelling the situation a "global crisis".[68]

Regarding the social effects of the HIV/AIDS pandemic, some sociologists suggest that AIDS has caused a "profound re-medicalisation of sexuality".[69][70]

There has been extensive research done with HIV since 2001 in the United States, The National Institutes of Health (NIH) which is an agency funded by the U.S department of Health and Human Services (HHS) has substantially improved the health, treatment, and lives of many individuals across the nation. The human immunodeficiency virus (HIV) is generally the precursor to AIDS. To this day there is no cure for this virus; However, treatment, education programs, proper medical care, and support have been made available.[citation needed]

NIH, is coordinated by the Office of AIDS Research (OAR) and this research carried out by nearly all the NIH Institutes and Centers, in both at NIH and at NIH-funded institutions worldwide. The NIH HIV/AIDS Research Program, represents the world's largest public investment in AIDS research.[71] Other agencies like the National Institute of Allergy and Infectious Diseases have also made substantial efforts to provide the latest and newest research and treatment available.[citation needed]

The NIH found that in certain areas of the world, the correlation in risky behaviors and the acquisition of HIV/AIDS is causational. Consistent drug usage and related risk behaviors, such as the exchange of sex for drugs or money, are linked to an increased risk of HIV acquisition in marginalized areas. NIAID and other NIH institutes work to develop and optimize harm reduction interventions that decrease the risk of drug use-associated and sexual transmission of HIV among injecting and non-injecting drug users.[72] Most organizations work collectively around the globe to understand, diagnose, treat, and battle the spread of this notorious disease, through the use of intervention and preventive programs the risk of acquiring HIV and the development of AIDS has dramatically dropped by 40% since its peak of cases back in 1998.[73]

Despite the advancements in scientific research and treatment, to this day there's no available cure for HIV/AIDS. Yet major efforts to contain the disease and improve the lives of many individuals through modernized anti-viral therapy have resulted in positive and promising results that may one day lead to a cure. The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) is one of the largest U.S. Government's response to the global HIV/AIDS epidemic and represents the largest commitment by any nation to address a single disease in history. PEPFAR provided HIV testing services for 79.6 million people in Fiscal Year 2019 and, as of September 30, 2019, supported lifesaving anti-retroviral therapy for nearly 15.7 million men, women, and children.[74] As of the end of 2019, 25.4 million people with HIV (67%) were accessing antiretroviral therapy (ART) globally. That means 12.6 million people are still waiting. HIV treatment access is key to the global effort to end AIDS as a public health threat.[74] Individuals who not only are aware of their condition but also are prescribed ART, are encouraged to remain consistent with their daily-dosage treatment so they can reduce the spread, viral load, and live happy and healthy lives.[citation needed]

Because HIV is more prevalent in urban areas of the United States, individuals living in rural areas generally don't participate or receive HIV diagnosis. The CDC found huge disparities in HIV cases between Northern and Southern regions of the Nation. At a rate of 15.9 the Southern regions account for a large number of reports of HIV; subsequently, regions like the North and Midwest account for general rates between 9 and 7.2 making it significantly lower in case prevalence.[75] The development of an HIV vaccine has made little progress in the last forty years, but thanks to the development of mRNA technology used to quickly create COVID-19 vaccines for the SARS-CoV2 virus, creation of an HIV vaccine seems much more promising. The greatest challenge in applying the strategies of the COVID-19 vaccine is that HIV has a much greater number of variants that its vaccine needs to address. [76]

According to the CDC, populations affected and with most reported cases of HIV are generally found in gay, bisexual, and other men who reported male-to-male sexual contact. In 2018, gay and bisexual men accounted for 69% of the 37,968 new HIV diagnoses and 86% of diagnoses among males. HIV doesn't only affect individuals in this category, heterosexuals tend to be affected by HIV as well. In 2018, heterosexuals accounted for 24% of the 37,968 new HIV diagnoses in the United States.

  • Heterosexual men accounted for 8% of new HIV diagnoses.
  • Heterosexual women accounted for 16% of new HIV diagnoses.[77]

UNAIDS also suggested that the individuals who may also be at risk of acquiring this disease are generally:

  • 28 times higher among men who have sex with men.
  • 29 times higher among people who inject drugs.
  • 30 times higher for sex workers.
  • 13 times higher for transgender people.[78]

Further Reading[edit]

Centers for Disease Control and Prevention. HIV Surveillance Report, 2020; vol. 33. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published May 2022.

"I am confident that Jamaica can end AIDS". www.unaids.org. Retrieved 2022-12-01.

Dangerous inequalities: World AIDS Day report 2022. Geneva: Joint United Nations Programme on HIV/AIDS; 2022. Licence: CC BY-NC-SA 3.0 IGO.

ENDING AIDS, ENDING INEQUALITIES: FAST-TRACK CITIES. Geneva: Joint United Nations Programme on HIV/AIDS; [Year]. Licence: CC BY-NC-SA 3.0 IGO.

"Equality ends AIDS". UNAIDS.ORG. Retrieved 2022-12-01.

"Survivors". survivors.unaids.org. Retrieved 2022-12-01.

References[edit]

  1. ^ "New HIV infections rose more than 20% in Latin America in the last decade, PAHO says - PAHO/WHO | Pan American Health Organization". www.paho.org. Retrieved 2022-12-11.
  2. ^ "Latin America and the Caribbean | UNAIDS". unaids.org. Retrieved 19 December 2016.
  3. ^ a b Aggleton, Peter; Parker. Framing the sexual subject: the politics of gender, sexuality, and power. Berkeley: University of California Press. ISBN 978-0-520-21838-3.{{cite book}}: CS1 maint: multiple names: authors list (link)
  4. ^ Carrillo, Karen Jaunita (30 September 2004). "HIV/AIDS training for C. America Garifuna health care workers". The New York Amsterdam News – via EBSCOhost.
  5. ^ Monge-Maillo, Begoña; López-Vélez, Rogelio; Norman, Francesca F.; Ferrere-González, Federico; Martínez-Pérez, Ángela; Pérez-Molina, José Antonio (1 April 2015). "Screening of Imported Infectious Diseases Among Asymptomatic Sub-Saharan African and Latin American Immigrants: A Public Health Challenge". The American Journal of Tropical Medicine and Hygiene. 92 (4): 848–856. doi:10.4269/ajtmh.14-0520. ISSN 0002-9637. PMC 4385785. PMID 25646257.
  6. ^ https://www.unaids.org/sites/default/files/media_asset/JC3032_AIDS_Data_book_2021_En.pdf
  7. ^ Monge-Maillo B, López-Vélez R, Norman FF, Ferrere-González F, Martínez-Pérez Á, Pérez-Molina JA (April 2015). "Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge". The American Journal of Tropical Medicine and Hygiene. 92 (4): 848–856. doi:10.4269/ajtmh.14-0520. PMC 4385785. PMID 25646257.
  8. ^ Health Profile: Papua New Guinea Archived 14 February 2009 at the Wayback Machine. United States Agency for International Development (September 2008). Accessed 20 March 2009.
  9. ^ a b "HIV/AIDS". WHO | Regional Office for Africa. Retrieved 2022-11-27.
  10. ^ "HIV/AIDS Factsheet". World Health Organization. Retrieved 2022-03-06.
  11. ^ "HIV data and statistics". www.who.int. Retrieved 2022-11-21.
  12. ^ Roser, Max; Ritchie, Hannah (2018-04-03). "HIV / AIDS". Our World in Data.
  13. ^ a b c d e "AIDSinfo | UNAIDS". aidsinfo.unaids.org. Retrieved 2022-11-27.
  14. ^ a b "Fact Sheet - WorldAidsDay 2021" (PDF). UNAIDS. 1 December 2021. Retrieved 7 March 2022.
  15. ^ "HIV Testing | HIV/AIDS | CDC". www.cdc.gov. 2022-06-09. Retrieved 2022-11-21.
  16. ^ "Addressing HIV-related Intersectional Stigma and Discrimination". National Institute of Mental Health (NIMH). Retrieved 2022-11-02.
  17. ^ Roser, Max; Ritchie, Hannah (2018-04-03). "HIV / AIDS". Our World in Data.
  18. ^ "UNAIDS data 2021". www.unaids.org. Retrieved 2022-11-22.
  19. ^ a b "UNAIDS World Aids Day Report" (PDF). publisher. 2011. Archived from the original (PDF) on 29 March 2019. Retrieved 12 March 2014. The ranges define the boundaries within which the actual numbers lie, based on the best available information.
  20. ^ a b c d e f g "Full report — In Danger: UNAIDS Global AIDS Update 2022". www.unaids.org. Retrieved 2022-11-22.
  21. ^ "Core epidemiology slides". www.unaids.org. Retrieved 2022-11-22.
  22. ^ "A5 NORTH AMERICA: MID-YEAR POPULATION ESTIMATES & SOUTH AMERICA: MID-YEAR POPULATION ESTIMATES", International Historical Statistics, Palgrave Macmillan, retrieved 2022-11-30
  23. ^ "HIV and AIDS". www.unicef.org. Retrieved 2022-11-27.
  24. ^ De Cock, Kevin M.; Fowler, Mary Glenn; Mercier, Eric; de Vincenzi, Isabelle; Saba, Joseph; Hoff, Elizabeth; Alnwick, David J.; Rogers, Martha; Shaffer, Nathan (2000-03-01). "Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries: Translating Research Into Policy and Practice". JAMA. 283 (9): 1175. doi:10.1001/jama.283.9.1175. ISSN 0098-7484.
  25. ^ Fleming, Alan F. (1997-06). "HIV and blood transfusion in sub-Saharan Africa". Transfusion Science. 18 (2): 167–179. doi:10.1016/S0955-3886(97)00006-4. {{cite journal}}: Check date values in: |date= (help)
  26. ^ a b "South Africa". www.unaids.org. Retrieved 2022-11-27.
  27. ^ a b c d e f g "2021 World AIDS Day report — Unequal, unprepared, under threat: why bold action against inequalities is needed to end AIDS, stop COVID-19 and prepare for future pandemics". www.unaids.org. Retrieved 2022-11-30.
  28. ^ Ogunbodede, E O; Folayan, M O; Adedigba, M A (2005-07-01). "Oral health-care workers and HIV infection control practices in Nigeria". Tropical Doctor. 35 (3): 147–150. doi:10.1258/0049475054620707. ISSN 0049-4755.
  29. ^ "Global Health Workforce statistics database". www.who.int. Retrieved 2022-11-30.
  30. ^ a b c d "Miles to go—closing gaps, breaking barriers, righting injustices". unaids.org. Retrieved 5 December 2019.
  31. ^ "UNAIDS data 2018". unaids.org. Retrieved 5 December 2019.
  32. ^ "WHO | Antiretroviral therapy (ART) coverage among all age groups". WHO. Retrieved 5 December 2019.
  33. ^ a b "Overview of HIV/AIDS Middle East and North Africa 2020". Statista. Retrieved 2022-11-22.
  34. ^ "HIV and AIDS in the Middle East and North Africa". PRB. Retrieved 2022-11-22.
  35. ^ a b c "AIDSinfo | UNAIDS". aidsinfo.unaids.org. Retrieved 5 December 2019.
  36. ^ a b c Fiona Samuels and Sanju Wagle 2011. Population mobility and HIV and AIDS: review of laws, policies and treaties between Bangladesh, Nepal and India Archived 20 September 2012 at the Wayback Machine. London: Overseas Development Institute
  37. ^ a b c d Pendse, Razia; Gupta, Somya; Yu, Dongbao; Sarkar, Swarup (2016-11-28). "HIV/AIDS in the South-East Asia region: progress and challenges". Journal of Virus Eradication. 2 (Suppl 4): 1–6. ISSN 2055-6640. PMC 5353351. PMID 28303199.
  38. ^ Gangcuangco LM, Tan ML, Berba RP (Sep 2013). "Prevalence and risk factors for HIV infection among men having sex with men in Metro Manila, Philippines" (PDF). Southeast Asian Journal of Tropical Medicine and Public Health. 44 (5): 810–816. PMID 24437316.
  39. ^ Gangcuangco, L.M.; Sumalapao2, D.E.; Tan, M.L.; Berba, R. Abstract: Changing risk factors for HIV infection among men having sex with men in Manila, Philippines. AIDS 2010 - XVIII International AIDS Conference. Archived from the original on 4 October 2013. Retrieved 2 October 2013.{{cite conference}}: CS1 maint: numeric names: authors list (link)
  40. ^ "Technical notes: Number of needles-syringes per PWID per year | Coalition for Global Hepatitis Elimination". www.globalhep.org. Retrieved 2022-11-21.
  41. ^ Pendse, Razia; Gupta, Somya; Yu, Dongbao; Sarkar, Swarup. "HIV/AIDS in the South-East Asia region: progress and challenges". Journal of Virus Eradication. 2 (Suppl 4): 1–6. ISSN 2055-6640. PMC 5353351. PMID 28303199.
  42. ^ "UNAIDS World Aids Day Report" (PDF). publisher. 2011. Archived from the original (PDF) on 29 March 2019. Retrieved 12 March 2014. The ranges define the boundaries within which the actual numbers lie, based on the best available information.
  43. ^ UNAIDS, WHO (2005). AIDS epidemic update 2005.
  44. ^ "HIV/AIDS in the Caribbean". JAMA. 285 (23): 2961. 2001-06-20. doi:10.1001/jama.285.23.2961. ISSN 0098-7484.
  45. ^ "State of the HIV Epidemic | Gilead HIV". www.gileadhiv.com. Retrieved 2022-11-20.
  46. ^ "HIV in the United States: At A Glance HIV Surveillance Supplemental Report 2019;24(1)". CDC. 2019.
  47. ^ "HIV Surveillance | Reports| Resource Library | HIV/AIDS | CDC". cdc.gov. 7 November 2019. Retrieved 21 November 2019.
  48. ^ "HIV in the United States: At A Glance". Centers for Disease Control and Prevention. USA.gov. Retrieved 6 June 2017.
  49. ^ "U.S. Statistics". HIV.gov. Retrieved 2022-12-11.
  50. ^ a b Campaign, Human Rights. "HIV and the LGBT Community | Human Rights Campaign". Human Rights Campaign. Retrieved 27 April 2016.
  51. ^ "HIV Among Gay and Bisexual Men" (PDF). Retrieved 1 January 2017.
  52. ^ "Estimating HIV Prevalence and Risk Behaviors of Transgender Persons in the United States: A Systematic Review". AIDS and Behavior.
  53. ^ "CDC FACT SHEET: Today's HIV/AIDS Epidemic" (PDF). Centers for Disease Control and Prevention. USA.Gov. Retrieved 6 June 2017.
  54. ^ "Injustice at Every Turn: A Look at Black Respondents in the National Transgender Discrimination Survey" (PDF). National Black Justice Coalition, National Center for Transgender Equality, and National Gay and Lesbian Task Force. Retrieved 7 April 2015.
  55. ^ "Kaiser Daily HIV/AIDS Report Summarizes Opinion Pieces on U.S. AIDS Epidemic". The Body – The Complete HIV/AIDS Resource. 20 June 2005. Archived from the original on 17 September 2018. Retrieved 27 December 2010.
  56. ^ "Report: Black U.S. AIDS rates rival some African nations". cnn.com.
  57. ^ Aylward, Andrew (3 June 2010). "White House summit on AIDS' impact on black men". SFGate. Retrieved 4 September 2020.
  58. ^ Arya M, Behforouz HL, Viswanath K (9 March 2009). "African American Women and HIV/AIDS: A National Call for Targeted Health Communication Strategies to Address a Disparity". The AIDS Reader. 19 (2): 79–84, C3. PMC 3695628. PMID 19271331.
  59. ^ CDC. HIV/AIDS Surveillance Report, 2005. Vol. 17. Rev ed. Atlanta: US Department of Health and Human Services, CDC: 2007:1–46. Available at http://www.cdc Archived 20 July 2013 at the Wayback Machine. gov/hiv/topics/surveillance/resources/reports/. Accessed 28 June 2007.
  60. ^ Machtinger, EL; Wilson, TC; Haberer, JE; Weiss, DS (Nov 2012). "Psychological trauma and PTSD in HIV-positive women: a meta-analysis". AIDS Behav. 16 (8): 2091–100. doi:10.1007/s10461-011-0127-4. PMID 22249954. S2CID 10718598.
  61. ^ "Addressing the Intersection of HIV/AIDS, Violence against Women and Girls, & Gender–Related Health Disparities" (PDF). whitehouse.gov. September 2013. Archived (PDF) from the original on 21 January 2017. Retrieved 11 April 2014 – via National Archives.
  62. ^ a b "HIV/AIDS Surveillance Report: Cases of HIV infection and AIDS in the United States and Dependent Areas" (PDF). Department of Health and Human Services. 2005. Archived from the original (PDF) on 27 September 2009. Retrieved 30 October 2009.
  63. ^ "AIDS epidemic in Washington, DC". pri.org. Retrieved 18 March 2018.
  64. ^ a b "Life or Meth". Retrieved 27 December 2010.
  65. ^ Canada, Public Health Agency of (2018-07-17). "Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets". www.canada.ca. Retrieved 2022-11-22.
  66. ^ "Eastern Europe and Central Asia may face an accelerated increase in new HIV infections and AIDS-related deaths because of the humanitarian crisis gripping the entire region". www.unaids.org. Retrieved 2022-12-10.
  67. ^ a b c Nakagawa, Fumiyo; Phillips, Andrew N.; Lundgren, Jens D. (2014-06). "Update on HIV in Western Europe". Current HIV/AIDS Reports. 11 (2): 177–185. doi:10.1007/s11904-014-0198-8. ISSN 1548-3568. {{cite journal}}: Check date values in: |date= (help)
  68. ^ United Nations Special Session on HIV/AIDS. New York, 25–27 June 2001 – http://www.un.org/ga/aids/conference.html
  69. ^ Aggleton, Peter; Parker, Richard Bordeaux; Barbosa, Regina Maria (2000). Framing the sexual subject: the politics of gender, sexuality, and power. Berkeley: University of California Press. ISBN 978-0-520-21838-3. p.3
  70. ^ Vance, Carole S. (1991). "Anthropology Rediscovers Sexuality: A Theoretical Comment". Social Science and Medicine. 33 (8): 875–884. doi:10.1016/0277-9536(91)90259-F. PMID 1745914.
  71. ^ "HIV Research Activities". HIV.gov. 2018-09-19. Retrieved 2020-11-12.
  72. ^ "HIV Prevention | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. Retrieved 2020-11-13.
  73. ^ "Global HIV & AIDS statistics — 2020 fact sheet". www.unaids.org. Retrieved 2020-11-13.
  74. ^ a b "Global Statistics". HIV.gov. 2020-07-07. Retrieved 2020-11-13.
  75. ^ CDC (2020-10-26). "HIV in the United States by Region". Centers for Disease Control and Prevention. Retrieved 2020-11-13.
  76. ^ "How COVID vaccines have boosted the development of an HIV vaccine". NPR.org. Retrieved 2022-12-11.
  77. ^ "HIV in the United States and Dependent Areas | Statistics Overview | Statistics Center | HIV/AIDS | CDC". www.cdc.gov. 2020-06-10. Retrieved 2020-11-13.
  78. ^ "Global HIV & AIDS statistics — 2020 fact sheet". www.unaids.org. Retrieved 2020-11-13.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Larsonem7825/Epidemiology_of_HIV/AIDS&oldid=1126880835"